Cardiovascular Therapeutics Q2
Unclaimed
Cardiovascular Therapeutics is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology with an H index of 59. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1440 €. The scope of the journal is focused on cardiovascular pharmacology, cardiovascular drugs, cardiovascular diseases. It has an SJR impact factor of 0,831 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,831.
Type: Journal
Type of Copyright: CC BY
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -



1440 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,831
SJR Impact factor59
H Index35
Total Docs (Last Year)138
Total Docs (3 years)1219
Total Refs486
Total Cites (3 years)138
Citable Docs (3 years)3.64
Cites/Doc (2 years)34.83
Ref/DocOther journals with similar parameters
Clinical and Translational Oncology Q2
Neuro-Oncology Practice Q2
Revista de Saude Publica Q2
Human Vaccines and Immunotherapeutics Q2
British Journal of Nutrition Q2
Compare this journals
Aims and Scope
Best articles by citations
Regenerative Therapy in Peripheral Artery Disease
View morePharmacokinetic Interaction of the Direct Renin Inhibitor Aliskiren with Furosemide and Extended-Release Isosorbide-5-Mononitrate in Healthy Subjects
View moreExternal Validity of the ARISTOTLE Trial in Real-Life Atrial Fibrillation Patients
View moreAdministration of Antiarrhythmic Drugs to Maintain Sinus Rhythm After Catheter Ablation for Atrial Fibrillation: A Meta-Analysis
View moreAllopurinol Treatment Reduces Arterial Wave Reflection in Stroke Survivors
View moreAntihypertensive Drugs and New-Onset Diabetes: A Retrospective Longitudinal Cohort Study
View moreResistant Hypertension and Renal Denervation Where to Now?
View moreAbout "Resting Heart Rate Does Not Reflect the Degree of Beta-Blockade in Subjects with Heart Failure on Chronic Beta-Blocker Therapy"
View moreWhat Should Medical Practitioners Know about the Role of Alternative Medicines in Cardiovascular Disease Management?
View morePlaque Thrombosis is Reduced by Attenuating Plaque Inflammation with Pioglitazone and is Evaluated by Fluorodeoxyglucose Positron Emission Tomography
View moreEffects of Multiple Doses of Clarithromycin on the Pharmacokinetics of Laropiprant in Healthy Subjects
View moreA Dosing Algorithm for Erythropoietin Alpha in Older Adults with Heart Failure and a Preserved Ejection Fraction
View moreNonequivalence of Inhaled and Nebulized Salbutamol in the Assessment of Endothelial Dysfunction
View moreSecondary Prevention in Concurrent Coronary Artery, Cerebrovascular, and Chronic Kidney Disease: Focus on Pharmacological Therapy
View morePentoxifylline in Heart Failure: A Meta-Analysis of Clinical Trials
View moreMedical Malpractice: A Cardiovascular Perspective
View moreBeneficial Effects of L- and N-type Calcium Channel Blocker on Glucose and Lipid Metabolism and Renal Function in Patients with Hypertension and Type II Diabetes Mellitus
View moreAssessment of Arterial Stiffness, A Translational Medicine Biomarker System for Evaluation of Vascular Risk
View moreHypertension, Dietary Salt Intake, and the Role of the Thiazide-Sensitive Sodium Chloride Transporter NCCT
View moreDifferences in Medical Treatment of Chronic Coronary Heart Disease Patients According to Medical Specialities
View moreNutraceuticals and Atherosclerosis: Human Trials
View moreNutraceuticals in Diabetes and Metabolic Syndrome
View moreThe Next Generation of Review for Cardiac Cell Therapies
View moreThe Association Between Bleeding and the Incidence of Warfarin Discontinuation in Patients with Atrial Fibrillation
View more
Comments